Aquestive Therapeutics Inc (AQST) — Capital Reinvestment Ratio
Latest as of March 2023:
0.00x
Aquestive Therapeutics Inc (AQST) has a Capital Reinvestment Ratio of 0.00x as of March 2023, meaning it reinvests 0% of its operating cash flow ($8.82 Million) in capital expenditures ($2.00K). See AQST cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$8.82 Million
USD
Capital Expenditures
$2.00K
USD
Data as of
Mar 2023
Most recent filing
Aquestive Therapeutics Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks Aquestive Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Aquestive Therapeutics Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for Aquestive Therapeutics Inc from 2017 to 2017. For live market cap and broader valuation context, see Aquestive Therapeutics Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.36x | $5.82 Million | $2.07 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow